BDTX
Black Diamond Therapeutics Inc.
Company Overview
| Mkt Cap | $186.75M | Price | $3.87 |
| Volume | 440.27K | Change | +1.31% |
| P/E Ratio | -2.7 | Open | $3.82 |
| Revenue | $3.1M | Prev Close | $3.82 |
| Net Income | $-69.7M | 52W Range | $1.20 - $4.45 |
| Div Yield | N/A | Target | $9.50 |
| Overall | 69 | Value | 80 |
| Quality | -- | Technical | 58 |
No chart data available
Stock Overview
Updated DailyBlack Diamond Therapeutics Inc. (BDTX) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $3.87 with a market capitalization of $186.75 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BDTX with a volume of 440K shares. The stock opened down 0.00% from yesterday's close of $3.82. Current analyst estimates project earnings of $0.35 per share for this year, with next year targeting $-0.89.
BDTX demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BDTX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 145.5%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 2, 2025 at 06:48 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDTX | $3.87 | +1.3% | 440.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Black Diamond Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW